1. Home
  2. HNST vs BLSM Comparison

HNST vs BLSM Comparison

Compare HNST & BLSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Honest Company Inc.

HNST

The Honest Company Inc.

N/A

Current Price

$4.76

Market Cap

492.4M

ML Signal

N/A

Logo BlossomHill Therapeutics Inc. Common Stock

BLSM

BlossomHill Therapeutics Inc. Common Stock

N/A

Current Price

$13.44

Market Cap

483.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
HNST
BLSM
Founded
2012
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
492.4M
483.4M
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
HNST
BLSM
Price
$4.76
$13.44
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$5.20
★ $35.40
AVG Volume (30 Days)
★ 1.8M
131.5K
Earning Date
11-05-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.90
N/A
Revenue
★ $371,317,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.17
N/A
P/E Ratio
$49.33
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.07
$11.22
52 Week High
$6.01
$27.99

Technical Indicators

Market Signals
Indicator
HNST
BLSM
Relative Strength Index (RSI) 46.54 42.76
Support Level $3.55 $12.93
Resistance Level $5.72 $17.53
Average True Range (ATR) 0.25 1.66
MACD -0.01 -0.06
Stochastic Oscillator 55.32 44.62

Price Performance

Historical Comparison
HNST
BLSM

About HNST The Honest Company Inc.

The Honest Co Inc is a personal care company dedicated to creating cleanly-formulated and sustainably-designed products for everyone from babies to adults. By combining thoughtful design with science-based innovation, the company delivers personal care products for everyone from babies to adults, spanning categories across wipes, personal care, diapers, and beauty. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.

About BLSM BlossomHill Therapeutics Inc. Common Stock

BlossomHill Therapeutics Inc is a clinical-stage biopharmaceutical company applying its intentional, chemistry-based approach to develop small molecule medicines that address unmet medical needs in cancer treatment. Its product pipeline includes two clinical-stage programs: BH-30643, an investigational, non-covalent, macrocyclic, brain active, mutant-selective OMNI-EGFR inhibitor for the treatment of epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), and BH-30236, an investigational macrocyclic CDC-like kinase (CLK) inhibitor being evaluated first in relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndromes (HR-MDS), and the preclinical-stage product candidate BH-501284 targeting activated KRAS.

Share on Social Networks: